tradingkey.logo
tradingkey.logo
검색

Sionna Therapeutics Inc

SION
관심 목록에 추가
3.330USD
-0.100-2.92%
종가 11-13 16:00(ET)
150.55M시가총액
손실P/E TTM

Sionna Therapeutics Inc 정보 회사

Sionna Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on researching and developing novel medicines for cystic fibrosis. It is advancing a pipeline of small molecules engineered to correct the defects caused by the F508del genetic mutation, which resides in nucleotide-binding domain 1 (NBD1). It is conducting ongoing Phase I trials of its two highly potent NBD1 stabilizers, SION-719 and SION-451, evaluating the safety, tolerability and pharmacokinetic (PK) profile of single and multiple ascending doses in healthy subjects. It is also developing a portfolio of cystic fibrosis transmembrane conductance regulator (CFTR) modulators designed to work synergistically with its NBD1 stabilizers to improve CFTR function. Its portfolio also includes Galicaftor (SION-2222) and SION-2851, which are TMD1-directed CFTR correctors; SION-109, an ICL4-directed CFTR corrector, and Navocaftor (SION-3067), is a clinical-stage potentiator of CFTR gating activity.

Sionna Therapeutics Inc 프로필

종목 코드 SION
회사 이름Sionna Therapeutics Inc
상장일Feb 07, 2025
CEOCloonan (Michael)
직원 수41
유형Ordinary Share
회계 연도 종료Feb 07
주소21 Hickory Drive, Suite 500
도시WALTHAM
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호02451
전화16178192020
웹사이트https://www.sionnatx.com/
종목 코드 SION
상장일Feb 07, 2025
CEOCloonan (Michael)

Sionna Therapeutics Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Michael (Mike) Cloonan
Mr. Michael (Mike) Cloonan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
765.39K
+28.49%
Mr. Michael (Mike) Cloonan
Mr. Michael (Mike) Cloonan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
765.39K
+28.49%
Mr. Michael (Mike) Cloonan
Mr. Michael (Mike) Cloonan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
765.39K
+28.49%
Ms. Jennifer Fitzpatrick, J.D.
Ms. Jennifer Fitzpatrick, J.D.
Chief Legal Officer, Head of Program Management
Chief Legal Officer, Head of Program Management
56.27K
--
Ms. Jennifer Fitzpatrick, J.D.
Ms. Jennifer Fitzpatrick, J.D.
Chief Legal Officer, Head of Program Management
Chief Legal Officer, Head of Program Management
56.27K
--
Ms. Jennifer Fitzpatrick, J.D.
Ms. Jennifer Fitzpatrick, J.D.
Chief Legal Officer, Head of Program Management
Chief Legal Officer, Head of Program Management
56.27K
--
Ms. Elena H. Ridloff
Ms. Elena H. Ridloff
Chief Financial Officer, Chief Business Officer
Chief Financial Officer, Chief Business Officer
--
--
Dr. Joshua B. (Josh) Resnick, M.D.
Dr. Joshua B. (Josh) Resnick, M.D.
Independent Director
Independent Director
--
--
Mr. Paul J. Clancy
Mr. Paul J. Clancy
Independent Chairman of the Board of Director
Independent Chairman of the Board of Director
--
--
Dr. Joanne Louise (Jo) Viney, Ph.D.
Dr. Joanne Louise (Jo) Viney, Ph.D.
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Michael (Mike) Cloonan
Mr. Michael (Mike) Cloonan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
765.39K
+28.49%
Mr. Michael (Mike) Cloonan
Mr. Michael (Mike) Cloonan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
765.39K
+28.49%
Mr. Michael (Mike) Cloonan
Mr. Michael (Mike) Cloonan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
765.39K
+28.49%
Ms. Jennifer Fitzpatrick, J.D.
Ms. Jennifer Fitzpatrick, J.D.
Chief Legal Officer, Head of Program Management
Chief Legal Officer, Head of Program Management
56.27K
--
Ms. Jennifer Fitzpatrick, J.D.
Ms. Jennifer Fitzpatrick, J.D.
Chief Legal Officer, Head of Program Management
Chief Legal Officer, Head of Program Management
56.27K
--
Ms. Jennifer Fitzpatrick, J.D.
Ms. Jennifer Fitzpatrick, J.D.
Chief Legal Officer, Head of Program Management
Chief Legal Officer, Head of Program Management
56.27K
--

자주 묻는 질문

Sionna Therapeutics Inc의 상위 5대 주주는 누구인가요?

Sionna Therapeutics Inc의 상위 5대 주주는 다음과 같습니다: Mr. Michael (Mike) Cloonan

Sionna Therapeutics Inc(SION)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Sionna Therapeutics Inc의 주식을 보유한 기관은 총 183곳이며, 이들이 보유한 주식의 총 가치는 약 46.20M로 전체 발행 주식의 102.34%를 차지합니다. 이는 2025Q4 대비 5837190.00 증가한 수치입니다.
tradingkey.logo
위험 경고: 저희 웹사이트와 모바일 앱은 특정 투자 상품에 대한 일반적인 정보만을 제공합니다. Finsights는 재정적 조언이나 투자 상품에 대한 추천을 제공하지 않으며, 이러한 정보 제공이 Finsights가 금융 조언이나 추천을 제공하는 것으로 해석되어서는 안 됩니다.
투자 상품은 투자 원금 손실을 포함한 상당한 투자 위험에 노출되어 있으며, 모든 사람에게 적합하지 않을 수 있습니다. 투자 상품의 과거 성과는 미래 성과를 보장하지 않습니다.
Finsights는 제3자 광고주나 제휴사가 저희 웹사이트나 모바일 앱 또는 그 일부에 광고를 게재하거나 전달할 수 있도록 허용할 수 있으며, 사용자가 광고와 상호작용하는 방식에 따라 이들로부터 보상을 받을 수 있습니다.
© 저작권: FINSIGHTS MEDIA PTE. LTD. 모든 권리 보유